Cosentyx is a biologic medication that is used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis. The safety of Cosentyx for elderly patients with comorbidities has been a topic of concern. However, according to recent studies, Cosentyx has been found to be safe and effective for elderly patients with comorbidities.

One study found that the efficacy and safety of biologic medications, including Cosentyx, were not significantly impacted by comorbidities in older adults with psoriasis [3]. Another study reported that Cosentyx is a safe and effective treatment option for elderly patients with psoriasis and psoriatic arthritis, including those with comorbidities such as cardiovascular disease, diabetes, and hypertension [2].

It is important to note that elderly patients may be more susceptible to adverse effects from medication due to age-related changes in organ function. Therefore, it is important for healthcare providers to carefully monitor elderly patients who are taking Cosentyx and to adjust the dosage as needed based on their individual health status.

In conclusion, based on the sources provided, Cosentyx appears to be a safe and effective treatment option for elderly patients with comorbidities such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. However, healthcare providers should carefully monitor elderly patients who are taking Cosentyx and adjust the dosage as needed based on their individual health status.

Sources:
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847154/
[3] https://www.hcplive.com/view/biologics-efficacy-safety-not-significantly-impacted-comorbidities-older-adults-psoriasis